Tamoxifen Tablet bulk supplier for pharma manufacturers

Tamoxifen Tablet 10 mg, 20 mg, 40 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg, 20 mg, 40 mg

Reference Brands: Nolvadex (USA)

Tamoxifen is a key oncology drug used to treat and prevent hormone receptor-positive breast cancer. Available in 10 mg, 20 mg, and 40 mg tablets, it's marketed under Nolvadex®, Soltamox®, and generics across the US and EU. GMP-compliant and ideal for B2B pharma supply.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Tamoxifen is a widely used oncology medication indicated for the treatment and prevention of hormone receptor-positive breast cancer in pre- and postmenopausal women. As a selective estrogen receptor modulator (SERM), it blocks estrogen’s effects in breast tissue, reducing the risk of cancer growth. Tamoxifen is available in 10 mg, 20 mg, and 40 mg oral tablet forms and marketed under brands like Nolvadex® and Soltamox®, as well as multiple generic alternatives in the US and EU. Ideal for pharma B2B buyers, Tamoxifen is manufactured under GMP compliance, ensuring reliable supply for oncology distributors and tender markets.

Tamoxifen Tablet — third party manufacturing & bulk supply

Tamoxifen Tablet 10 mg, 20 mg, 40 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tamoxifen Tablet is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tamoxifen Tablet listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tamoxifen Tablet →

Back to Listing

Frequently Asked Questions

Tamoxifen citrate is used for the treatment and prevention of hormone receptor-positive breast cancer in both pre-menopausal and post-menopausal women and in some cases men. It is also used to reduce the risk of developing breast cancer in high-risk patients.

Tamoxifen is made from the active pharmaceutical ingredient tamoxifen citrate, which is a selective estrogen receptor modulator (SERM) that blocks the effects of estrogen in breast tissue.

Common trade names include Nolvadex and Soltamox.

The original brand Nolvadex was developed by AstraZeneca. Today, Tamoxifen is manufactured by many global pharmaceutical companies as a generic medicine in USA, EU, UK, and other regions.

The generic name is tamoxifen citrate.

Major brand names include Nolvadex and Soltamox, along with multiple regional generic brand versions.

Tamoxifen is manufactured in multiple countries including the USA, UK, EU member states, India, and other regulated pharmaceutical manufacturing regions depending on the marketing authorization holder.